(Press-News.org) Contact information: Haley Bridger
hbridger@broadinstitute.org
617-714-7968
Broad Institute of MIT and Harvard
Multiple myeloma study uncovers genetic diversity within tumors
Subpopulations of cells could have implications for treatment
The most comprehensive genetic study to date of the blood cancer multiple myeloma has revealed that the genetic landscape of the disease may be more complicated than previously thought. Through results published in Cancer Cell today, a team of Broad researchers has shown that an individual patient's tumor can harbor populations of cancer cells equipped with different mutations. These findings could have therapeutic implications for patients in the future.
"What this new work shows us is that when we treat an individual patient with multiple myeloma, it's possible that we're not just looking at one disease, but at many – in the same person, there could be cancer cells with different genetic make-ups," said co-senior author Todd Golub, the Broad Institute's Chief Scientific Officer and Charles A. Dana Investigator in Human Cancer Genetics at the Dana-Farber Cancer Institute. Golub is also a professor at Harvard Medical School and an investigator at Howard Hughes Medical Institute. "These findings indicate a need to identify the extent of genetic diversity within a tumor as we move toward precision cancer medicine and genome-based diagnostics."
In a detailed study of samples from more than 200 multiple myeloma patients, Golub and colleagues identified frequent mutations in several key genes known to play an important role in cancer including KRAS, NRAS, and BRAF. But they found that many of these telltale mutations were not present in all cancer cells within a tumor – instead, they were often found in only a smaller fraction of cells, known as a subclonal population.
Many promising cancer therapies used in treatment today target a specific genetic mutation. This new work suggests that such targeted therapies may have limitations in patients whose tumors are made up of these subclonal populations.
The research team performed follow-up experiments in the lab to explore some of the therapeutic implications, looking specifically at BRAF, a cancer gene for which several inhibitors, or drugs, exist. Previous studies indicated that around four percent of multiple myeloma patients may have mutations in this gene, and a recent report on a single multiple myeloma patient treated with drugs targeting BRAF showed promising results. BRAF inhibitors have also been used to treat patients with melanoma and other forms of cancer. In the lab, however, the research team found evidence that treating a tumor harboring subclonal BRAF mutations with one of these targeted drugs may at best kill a fraction of the cells, and at worst, stimulate another cancer cell subpopulation to grow.
"There's clearly potential for these drugs in some patients with multiple myeloma, but we show that there are also potential problems for others," said co-first author Jens Lohr an associated scientist at the Broad and a medical oncologist at Dana-Farber. "If a patient has a BRAF mutation in less than 100 percent of his cells, or if he has mutations in KRAS or NRAS at the same time, his oncologist would want to think through the potential pitfalls before giving the inhibitor."
Resistance – or the ability for tumors to shrink and then grow back – has become a major hurdle in treating patients with targeted therapies such as BRAF inhibitors. The new research suggests that subclonal populations could be one of the potential reasons many patients suffer relapse after treatment.
To take a genetic census of the populations of cancer cells that make up a tumor, the researchers used a computational technique known as ABSOLUTE, developed by the Broad's Cancer Genome Computational Analysis group, led by Broad associate member and co-senior author Gad Getz. In this study, ABSOLUTE was used to analyze information from many samples, but it's also feasible to use the algorithm to analyze information from a single patient. This could allow cancer researchers to examine a specific tumor and determine what fraction of cells contains a BRAF mutation or another such mutation.
The problem of subclonal populations is not unique to multiple myeloma. Researchers are applying the same technique to explore other forms of cancer to look for populations of genetically diverse cells within a single tumor.
"In order to appropriately choose targeted therapy, we have to have those studies," said Lohr. "Matching the right drug to the right patient isn't as easy as finding a mutation and having a drug that targets it. We have to keep this additional parameter of heterogeneity in mind."
###
All of the data generated through this project will be made publicly available to cancer researchers worldwide through the Multiple Myeloma Genomics Portal. Funding for this project was provided by the Multiple Myeloma Research Foundation and tissue samples were provided by the Multiple Myeloma Research Consortium tissue bank. This work was also supported by an NIH grant and a Conquer Cancer Foundation Young Investigator Award.
Co-first authors Lohr, Petar Stojanov, and Scott L. Carter contributed equally to this work. Other researchers who contributed to this work include Peter Cruz-Gordillo, Michael S. Lawrence, Daniel Auclair, Carrie Sougnez, Birgit Knoechel, Joshua Gould, Gordon Saksena, Kristian Cibulskis, Aaron McKenna, Michael A. Chapman, Ravid Straussman, Joan Levy, Louise M. Perkins, Jonathan J. Keats, Steven E. Schumacher, Mara Rosenberg, and members of The Multiple Myeloma Research Consortium.
-Written by Haley Bridger, Broad Institute
Paper cited:
Lohr JG et al. "Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy." Cancer Cell. DOI: 10.1016/j.ccr.2013.12.015
About the Broad Institute of Harvard and MIT
The Eli and Edythe L. Broad Institute of Harvard and MIT was launched in 2004 to empower this generation of creative scientists to transform medicine. The Broad Institute seeks to describe all the molecular components of life and their connections; discover the molecular basis of major human diseases; develop effective new approaches to diagnostics and therapeutics; and disseminate discoveries, tools, methods and data openly to the entire scientific community.
Founded by MIT, Harvard and its affiliated hospitals, and the visionary Los Angeles philanthropists Eli and Edythe L. Broad, the Broad Institute includes faculty, professional staff and students from throughout the MIT and Harvard biomedical research communities and beyond, with collaborations spanning over a hundred private and public institutions in more than 40 countries worldwide. For further information about the Broad Institute, go to http://www.broadinstitute.org.
About Dana-Farber Cancer Institute
Dana-Farber Cancer Institute is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center, designated a comprehensive cancer center by the National Cancer Institute. It provides adult cancer care with Brigham and Women's Hospital as Dana-Farber/Brigham and Women's Cancer Center and it provides pediatric care with Boston Children's Hospital as Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Dana-Farber is the top ranked cancer center in New England and fifth nationally, according to U.S. News & World Report, and one of the largest recipients among independent hospitals of National Cancer Institute and National Institutes of Health grant funding. Follow Dana-Farber on Facebook and Twitter.
Multiple myeloma study uncovers genetic diversity within tumors
Subpopulations of cells could have implications for treatment
2014-01-13
ELSE PRESS RELEASES FROM THIS DATE:
BU study: 1 question may gauge the severity of unhealthy drug and alcohol use
2014-01-13
BU study: 1 question may gauge the severity of unhealthy drug and alcohol use
Primary care physicians seeking to determine whether a patient's drug or alcohol use is problematic often have to rely on lengthy questionnaires containing dozens of items with multiple ...
2 players produce destructive cascade of diabetic retinopathy
2014-01-13
2 players produce destructive cascade of diabetic retinopathy
Augusta, Ga. - The retina can be bombarded by reactive oxygen species in diabetes, prompting events that destroy healthy blood vessels, form leaky new ones and ruin vision.
Now ...
Heart attack survivors paint a complex picture of adhering to medicine
2014-01-13
Heart attack survivors paint a complex picture of adhering to medicine
Heart attack survivors of different races and genders are about equally likely to be on medications that reduce the risk of another heart attack and other potentially life-threatening ...
Benefits of cognitive training can last 10 years in older adults
2014-01-13
Benefits of cognitive training can last 10 years in older adults
INDIANAPOLIS -- Exercises meant to boost mental sharpness can benefit older adults as many as 10 years after they received the cognitive training, researchers said Monday.
In a study published in the Journal ...
New discovery could stimulate plant growth and increase crop yields, researchers say
2014-01-13
New discovery could stimulate plant growth and increase crop yields, researchers say
Scientists led by experts at Durham University have discovered a natural mechanism in plants that could stimulate their growth even under stress and potentially lead to ...
Researchers investigating how to make PET imaging even sweeter
2014-01-13
Researchers investigating how to make PET imaging even sweeter
Mount Sinai Heart leads international research team testing new sugar-based tracer to help in the cardiovascular imaging hunt for inflamed high-risk, vulnerable ...
Enforcement and anti-poaching measures set to fail
2014-01-13
Enforcement and anti-poaching measures set to fail
In a paper published in Conservation Letters, researchers from the University of Kent's Durrell Institute of Conservation and Ecology (DICE) argue that despite record levels of funding being invested in enforcement ...
Understanding secondary light emission by plasmonic nanostructures may improve medical imaging
2014-01-13
Understanding secondary light emission by plasmonic nanostructures may improve medical imaging
"Plasmonic nanostructures are of great current interest as chemical sensors, in vivo imaging agents, and for photothermal therapeutics," explained ...
Bragging rights: MSU study shows that interventions help women's reluctance to discuss accomplishments
2014-01-13
Bragging rights: MSU study shows that interventions help women's reluctance to discuss accomplishments
BOZEMAN, Mont. -- A study published by Jessi L. Smith, professor of psychology at Montana State University, and Meghan Huntoon, who was Smith's student at MSU ...
Study: Kidney cancer patients preserve kidney function with robot-assisted partial nephrectomy
2014-01-13
Study: Kidney cancer patients preserve kidney function with robot-assisted partial nephrectomy
LAST 30 PRESS RELEASES:
Pink skies
Monkeys are world’s best yodellers - new research
Key differences between visual- and memory-led Alzheimer’s discovered
% weight loss targets in obesity management – is this the wrong objective?
An app can change how you see yourself at work
NYC speed cameras take six months to change driver behavior, effects vary by neighborhood, new study reveals
New research shows that propaganda is on the rise in China
Even the richest Americans face shorter lifespans than their European counterparts, study finds
Novel genes linked to rare childhood diarrhea
New computer model reveals how Bronze Age Scandinavians could have crossed the sea
Novel point-of-care technology delivers accurate HIV results in minutes
Researchers reveal key brain differences to explain why Ritalin helps improve focus in some more than others
Study finds nearly five-fold increase in hospitalizations for common cause of stroke
Study reveals how alcohol abuse damages cognition
Medicinal cannabis is linked to long-term benefits in health-related quality of life
Microplastics detected in cat placentas and fetuses during early pregnancy
Ancient amphibians as big as alligators died in mass mortality event in Triassic Wyoming
Scientists uncover the first clear evidence of air sacs in the fossilized bones of alvarezsaurian dinosaurs: the "hollow bones" which help modern day birds to fly
Alcohol makes male flies sexy
TB patients globally often incur "catastrophic costs" of up to $11,329 USD, despite many countries offering free treatment, with predominant drivers of cost being hospitalization and loss of income
Study links teen girls’ screen time to sleep disruptions and depression
Scientists unveil starfish-inspired wearable tech for heart monitoring
Footprints reveal prehistoric Scottish lagoons were stomping grounds for giant Jurassic dinosaurs
AI effectively predicts dementia risk in American Indian/Alaska Native elders
First guideline on newborn screening for cystic fibrosis calls for changes in practice to improve outcomes
Existing international law can help secure peace and security in outer space, study shows
Pinning down the process of West Nile virus transmission
UTA-backed research tackles health challenges across ages
In pancreatic cancer, a race against time
Targeting FGFR2 may prevent or delay some KRAS-mutated pancreatic cancers
[Press-News.org] Multiple myeloma study uncovers genetic diversity within tumorsSubpopulations of cells could have implications for treatment